DNTH R&D Expenses

Dianthus Therapeutics Inc · R&D Expenses

DNTH logo

DNTH R&D Expenses

Latest reported$48.69M
DNTH Quarterly R&D Expenses ($3.32M → $48.69M)
High-resolution chart · PNG

DNTH r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Dianthus Therapeutics Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
48,686,000
34,528,000
59,895,000
32,488,999
26,251,000
27,003,000
26,413,000
25,544,000
18,070,000
13,078,000
8,781,000
7,960,000
10,253,000
5,847,000
9,831,000
7,218,000
10,407,000
15,337,000
12,579,000
10,263,000
10,650,000
11,728,000
12,256,000
11,786,000
12,610,000
13,963,000
18,714,000
16,524,000
13,433,000
10,537,000
12,390,000
11,418,000
9,683,000
7,849,000
5,551,000
5,210,000
13,816,000
3,322,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.